Titre :
  • Efficacy of letrozole extended adjuvant therapy according to estrogen receptor and progesterone receptor status of the primary tumor: National Cancer Institute of Canada Clinical Trials Group MA.17.
Auteur : Goss, Paul E ; Ingle, James N ; Martino, S ; Robert, Nicholas J ; Muss, Hyman B ; Piccart-Gebhart, Martine ; Castiglione, Monica ; Tu, Dongsheng ; Shepherd, L ; Pritchard, Kathleen ; Livingston, Robert ; Davidson, Nancy E ; Norton, Larry ; Perez, Edith A ; Abrams, Jeffrey S ; Cameron, David A ; Palmer, Michael J ; Pater, Joseph L ; National Cancer Institute of Canada Clinical Trials Group MA.17
Informations sur la publication : Journal of clinical oncology, 25, 15, (page 2006-2011)
Statut de publication : Publié, 2007-05
Sujet CREF : Sciences bio-médicales et agricoles
Mots-clés MeSH : Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
Breast Neoplasms -- drug therapy
Breast Neoplasms -- metabolism
Breast Neoplasms -- pathology
Canada -- epidemiology
Chemotherapy, Adjuvant
Disease-Free Survival
Double-Blind Method
Female
Humans
Middle Aged
Nitriles -- administration & dosage
Placebos
Postmenopause
Receptors, Estrogen -- metabolism
Receptors, Progesterone -- metabolism
Retrospective Studies
Survival Rate
Tamoxifen -- administration & dosage
Treatment Outcome
Triazoles -- administration & dosage
Note : Comparative Study
Journal Article
Randomized Controlled Trial
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langue :
  • Anglais
Identificateurs : urn:issn:0732-183X 
info:doi/10.1200/JCO.2006.09.4482
info:pii/JCO.2006.09.4482
info:pmid/17452676